Evidence map›Paper›PMID 22037601›Full record

ArticleNature immunology2011

Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals.

Patrick J Brennan, Raju V V Tatituri, Manfred Brigl, Edy Y Kim, Amit Tuli, Joseph P Sanderson, Stephan D Gadola, Fong-Fu Hsu, Gurdyal S Besra, Michael B Brenner

Abstract read
In one paragraph

Article in Nature immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 184 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 1 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 1 synthesis or guideline pooled it, 310 citations in OpenAlex.

  1. Myocardial Immune Cells: The Basis of Cardiac Immunology.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Novel lipid antigens for NKT cells in cancer.Frontiers in immunology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. CD8Frontiers in immunology · 2022
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Article

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Patrick J BrennanDepartment of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Raju V V Tatituri
Manfred Brigl
Edy Y Kim
Amit Tuli
Joseph P Sanderson
Stephan D Gadola
Fong-Fu Hsu
Gurdyal S Besra
Michael B Brenner
Brigham and Women's Hospital · USHarvard University · USUniversity of Southampton · GBUniversity of Birmingham · GBWashington University in St. Louis · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
ZINC DEFICIENCY &PROTEIN EXPRESSION IN RAT OLFACTORY BULBSP41RR005351 · NCRR · UNIVERSITY OF GEORGIA (UGA) · PI VENOT, ANDRE · 1989 to 2011
$18.4M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 1985 to 2011
$16.0M
RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
T LYMPOHOCYTE RECOGNITIONR01AI028973 · NIAID · DANA-FARBER CANCER INSTITUTE · PI BRENNER, MICHAEL B. · 1990 to 2014
$4.5M
CD1d-restricted T Cell Self-antigens and InfectionR01AI063428 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2005 to 2015
$3.9M
CD1d-restricted NKT cells in microbial infectionK08AI077795 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRIGL, MANFRED · 2008 to 2012
$782k
Arthritis Research UK 18892Medical Research Council G0400421NCRR NIH HHS P41 RR000954NCRR NIH HHS P41 RR005351NCRR NIH HHS P41-RR00954NCRR NIH HHS P41-RR05351NHLBI NIH HHS T32 HL007633NHLBI NIH HHS T32HL007633NIAID NIH HHS K08 AI077795NIAID NIH HHS K08AI077795NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI028973NIAID NIH HHS R01 AI063428NIAID NIH HHS R01AI063428NIAID NIH HHS T32 AI007306NIAID NIH HHS T32AI007306NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30-DK56341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS P60-DK20579Wellcome TrustWellcome Trust 084923/B/08/Z
6 · The paper itself

Abstract

Invariant natural killer T cells (iNKT cells) have a prominent role during infection and other inflammatory processes, and these cells can be activated through their T cell antigen receptors by microbial lipid antigens. However, increasing evidence shows that they are also activated in situations in which foreign lipid antigens would not be present, which suggests a role for lipid self antigen. We found that an abundant endogenous lipid, β-D-glucopyranosylceramide (β-GlcCer), was a potent iNKT cell self antigen in mouse and human and that its activity depended on the composition of the N-acyl chain. Furthermore, β-GlcCer accumulated during infection and in response to Toll-like receptor agonists, contributing to iNKT cell activation. Thus, we propose that recognition of β-GlcCer by the invariant T cell antigen receptor translates innate danger signals into iNKT cell activation.

Indexed as

AnimalsAutoantigensAutoimmunityBacterial InfectionsCell LineGlycosphingolipidsHumansLymphocyte ActivationLymphoid TissueMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutNatural Killer T-CellsReceptors, Antigen, T-CellAutoantigensGlycosphingolipidsReceptors, Antigen, T-Cell

Identifiers

PMID22037601
PMCPMC3242449
OpenAlexW2102355478

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.